Visceral leishmaniasis: Comparative study in patients with and without HIV infection;Leishmaniasis visceral: Estudio comparativo de pacientes con y sin infeccion por el virus de la inmunodeficiencia humana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 10, 1999, Pages 515-520

  Reus, Sergio ^a   Sánchez, Rosario ^b   Portilla, Joaquín ^b   Boix, Vicente ^b   Priego, Manuel ^b   Merino, Esperanza ^b   Román, Francisco ^b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b NONE

Author keywords

AIDS; HIV infection; Leishmaniasis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANTIRETROVIRUS AGENT; FLUCONAZOLE; LACTATE DEHYDROGENASE; MEGLUMINE ANTIMONATE; PENTAMIDINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GINGIVA; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LYMPH NODE BIOPSY; LYMPHOCYTE COUNT; MALE; MORTALITY; PROGNOSIS; REINFECTION; SUPERINFECTION; TREATMENT FAILURE; VISCERAL LEISHMANIASIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIPROTOZOAL AGENTS; FEMALE; HIV-1; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 0342614876     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R et al. Leishmania and Human Immunodeficiency Virus Coinfection: the First 10 years. Clin Microbiol Rev 1997; 10: 298-319.
2. Kurtzhals JA, Hey S, Jardim A, Kemp M, Schaefer U, Odera EO et al. Dichotomy of the human. T cell response to Leishmania antigens. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol 1994; 96: 416-421.
3. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151-177.
4. Montalbán C, Calleja JL, Erice A, Laguna F, Clotet B, Podzamezer D et al. Visceral leishmaniasis in patients infected with human immunodeficiency virus. J Infect 1990; 21: 261-270.
5. Altés J, Salas A, Riera M, Udina M, Galmés A, Balanzat J et al. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 1.991; 5: 201-207.
6. Sanz MM, Rubio R, Casillas A, Guijarro C, Costa JR, Martínez R et al. Visceral leishmaniasis in HIV-infected patients. AIDS 1991; 5: 1.272-1.274.
7. Medrano FD, Hernández-Quero J, Jiménez E, Pineda JA, Rivero A, Sánchez-Quijano A et al. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS 1992; 6: 1.499-1.503.
8. Ribera E, Cucurrull E, Ocaña I, Vallespí T, Gasser I, Juste C. Leishmaniasis visceral en pacientes con infección por VIH. Enferm Infecc Microbiol Clin 1995; 13: 73-79.
9. Alvar J, Gutiérrez-Solar B, Pachón I, Calbacho E, Ramírez M, Vallés R et al. AIDS and Leishmania infantum: new approaches for a new epidemiological problem. Clin Dermatol 1996; 14: 241-246.
10. Berenguer J, Gómez-Campderá F, Padilla B, Rodríguez-Ferrero M, Anaya F, Moreno S et al. Visceral leishmaniasis (Kala-azar) in transplant recipients. Transplantation 1998; 65: 1.401-1.404.
11. Portilla J, Rosas JC, Casellas JA, Abad A, Monpel A, Palmero MF. Leishmaniasis visceral en Alicante. Análisis de 21 casos. Rev Clin Esp 1990; 187: 53-55.
12. Torrús D, Boix V, Massa B, Portilla J, Pérez-Mateo M. Fluconazole plus allopurinol in treatment of visceral leishmaniasis. J Antimicrob Chemother 1996; 37: 1.042-1.043.
13. Boletín Microbiológico semanal 13-14/88. Centro Nacional de Epidemiología. Instituto de la Salud Carlos III.
14. Mariscal F, Domínguez B, Lenguas F, Martínez JM, Galván B. Kala-azar en el hospital de enfermedades infecciosas. Revisión de 104 casos. Rev Clin Esp 1980; 159: 47-50.
15. Martínez P, de la Vega E, Laguna F, Soriano V, Puente S, Moreno V et al. Diagnosis of visceral leishmaniasis in. HIV-infected individuals using peripheral blood smears. AIDS 1993; 7: 227-230.
16. Medrano FJ, Jiménez-Mejías E, Calderón E, Regordán C, Leal M. An easy and quick method for the diagnosis of visceral leishmaniasis In HIV-1-infected individuals. AIDS 1993; 13: 1.399.
17. Molina R, López-Vélez R, Gutiérrez-Solar B, Jiménez MI, Alvar J. Isolation of Leishmania infantum from the blood of a patient with AIDS using sandflies. Trans R Soc Trop Med Hyg 1992; 86: 518.
18. Liew FY, O'Donnell. Immunology of leishmaniasis. Adv Parasitol 1993; 32: 161-259.
19. World Health Organization. Report on the consultative meeting on Leishmania/HIV coinfection. WHO/LEISH/95.35, p. 1-14. Ginebra: World Health Organization, 1995.
20. Fernández-Guerrero ML, Agudo JM, Buzón L, Barros C, Montalbán C, Martín T et al. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987; 83: 1.098-1.102.
21. Laguna F, García-Samaniego J, Moreno V, González-Lahoz JM. Prevalence of gastrointestinal leishmaniasis in Spanish HIV-positive patients with digestive symptoms. Am J Gastroenterol 1994; 89: 1.606.
22. Laguna F, García-Samaniego J, Soriano V, Valencia E, Redondo C, Alonso MJ et al. Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis 1994; 19: 48-53.
23. Romeu J, Sirera G, Ferrándiz C, Carreres A, Condom MJ, Clotet B. Visceral leishmaniasis involving lung and a cutaneous Kaposi's sarcoma lesion. AIDS 1991; 5: 1.272.
24. Del Giudice P. Leishmania infection occurring in herpes zoster lesions in an HIV positive patient. Br J Dermatol 1996; 135: 1.005-1.006.
25. González Anglada MI, Peña JM, Barbado FJ, González JJ, Redondo C, Galera C et al. Two cases of laryngeal leishmaniasis in patients infected with HIV. Eur J Clin Microbiol Infect Dis 1994; 13: 509-511.
26. Heudier P, Tillan B, Garnier G, Marty P, Fuzibet G, Dujardin P. Localisation pulmonaire d'une leishmaniose visceral au cours de l'infection, par le VIII. Presse Med 1993; 22: 1.060.
27. Rosenthal E, Marty P, Pesce A. Leishmania in broncoalveolar lavage. Ann Intern Med 1991; 114: 1.064-1.065.
28. Mondain-Miton V, Toussaint-Gari M, Hofmann P, Marty P, Carles M, De Salvados F et al. Atypical leishmaniasis in a patient infected with human immunodeficiency virus. Clin. Infect Dis 1995; 21: 663-665.
29. Berenguer J, Moreno S, Cercenado E, Barnaldo de Quirós JC, García de la Guente A, Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1989; 111: 129-132.
30. Torrús D, Massa B, Boix V, Portilla J, Pérez-Mateo M. Meglumine antimoniate-induced pancreatitis. Am J Gastroenterol 1996; 91: 820-821.
31. Gutiérrez F, Moya I, Ortiz V, Pozuelo A. Agranulocitosis por glucantime (antimoniato de N-metilglucamina) durante el tratamiento del Kala-azar. Med Clin (Barc) 1988; 86: 437.
32. Fernández Martín J, Barbado FJ, Gil Aguado A, Vázquez JJ, Kala-azar y agranulocitosis. Med Clin (Barc) 1986; 86: 84.
33. Laguna F, López-Vélez R, Pulido F, Salas A, Torre-Cisneros J, Torres E et al. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. AIDS 1999; 13: 1.063-1.069.
34. Lazanas MC, Tsekes GA, Papandreou S, Harhalakis N, Scandali A, Nikiforakis E et al. Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds. AIDS 1993; 7: 1.018-1.019.
35. Torre-Cisneros J, Villanueva JL, Kindelan JM, Jurado R, Sánchez-Guijo P. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin Infect Dis 1993; 17: 625-627.
36. Ribera E, Ocaña I, Otero J, Cortés E, Gasser I, Pahissa A. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med 1996; 100: 496-501.
37. Pérez-Molina JA, López-Vélez R, Montilla P, Guerrero A. Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients. AIDS 1996; 10: 237-238.
38. López M, Gil A, Lavilla P, Pintado V, Valencia E, Martínez P et al. Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases. J Antimicrob Chemother 1993; 32: 657-659.
39. Lafeuillade A, Chaffanjon P, Delbeque E, Quilichini R. Maintenance itraconazole for visceral leishmaniasis in HIV infection. Am J Med 1992; 92: 449.